This method to reverse cellular ageing is about to be tested in humans

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs.

In First Human Trial, Zombie Cancer Cells Train the Body to Fight Tumors

A small trial is testing a decades-old method that transforms cancer cells into a "vaccine" to prevent recurrence.

SingularityHub
Pig Lung Transplanted Into a Human in Major Scientific First

A genetically modified pig lung transplanted into a brain-dead human patient functioned for nine days in a new achievement that reveals both the promise and significant challenges of xenotransplantation.

ScienceAlert
Common supplement reverses premature aging in landmark human trial

A rare genetic disorder called Werner syndrome causes premature aging and devastating health complications from an early age, yet treatment options have been lacking. New hope emerges from Chiba University, where researchers conducted the first clinical trial using nicotinamide riboside (NR), a precursor to NAD+ that s been linked to anti-aging effects. The double-blind trial revealed that NR not only safely boosted NAD+ levels but also improved cardiovascular health, reduced skin ulcers, and helped protect kidney function in patients.

ScienceDaily
Tick-killing pill shows promising results in human trial

Should it pan out, the pill would be a new weapon against Lyme disease.

Ars Technica
'Cancer-killing pill' that appears to 'annihilate' solid tumours is now being tested on humans

Sky